Analysis | Metabolite Name | Measured Value | Units | Treatment | Timepoint |
---|---|---|---|---|---|
GCMS Positive ion mode | C17:0 | 1.4 | nM | Early ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C17:0 | 1.64 | nM | Early ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C17:0 | 1.7 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 1.74 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 1.8 | nM | Early ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C17:0 | 1.8 | nM | Late ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C17:0 | 1.99 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 2.19 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 2.43 | nM | Early ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C17:0 | 2.66 | nM | Late ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C17:0 | 2.73 | nM | Early ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C17:0 | 2.74 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 2.75 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 3.08 | nM | Late ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C17:0 | 3.2 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 3.21 | nM | Late ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C17:0 | 3.23 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 3.25 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 3.27 | nM | Early ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C17:0 | 3.34 | nM | Late ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C17:0 | 3.56 | nM | Early ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C17:0 | 3.71 | nM | Early ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C17:0 | 3.74 | nM | Late ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C17:0 | 3.8 | nM | Late ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C17:0 | 3.8 | nM | Late ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C17:0 | 3.8 | nM | Late ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C17:0 | 3.91 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 3.93 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 4.34 | nM | Late ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C17:0 | 4.49 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 4.54 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 4.6 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 4.72 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 5.06 | nM | Early ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C17:0 | 5.22 | nM | Late ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C17:0 | 5.38 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 5.45 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 5.49 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 5.57 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 5.75 | nM | Late ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C17:0 | 5.79 | nM | Late ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C17:0 | 5.8 | nM | Early ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C17:0 | 5.96 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 5.97 | nM | Early ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C17:0 | 6.02 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 6.12 | nM | Late ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C17:0 | 6.2 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 6.2 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 6.27 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 6.42 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 6.43 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 6.45 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 6.5 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 6.71 | nM | Late ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C17:0 | 6.8 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 6.81 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 6.81 | nM | Late ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C17:0 | 6.9 | nM | Early ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C17:0 | 7.1 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 7.15 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 7.2 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 7.21 | nM | Late ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C17:0 | 7.32 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 7.36 | nM | Early ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C17:0 | 7.47 | nM | Late ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C17:0 | 7.49 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 7.52 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 7.54 | nM | Early ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C17:0 | 7.54 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 7.56 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 7.59 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 7.59 | nM | Late ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C17:0 | 7.61 | nM | Late ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C17:0 | 7.7 | nM | Early ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C17:0 | 7.75 | nM | Early ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C17:0 | 7.75 | nM | Early ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C17:0 | 7.81 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 7.9 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 7.94 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 8.06 | nM | Late ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C17:0 | 8.16 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 8.18 | nM | Late ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C17:0 | 8.25 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 8.3 | nM | Early ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C17:0 | 8.38 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 8.45 | nM | Early ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C17:0 | 8.72 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 8.8 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 8.84 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 8.84 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 9.01 | nM | Late ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C17:0 | 9.56 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 9.62 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 9.87 | nM | Early ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C17:0 | 9.91 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C17:0 | 10 | nM | Early ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C17:0 | 10.4 | nM | Early ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C17:0 | 10.4 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 10.5 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C17:0 | 10.6 | nM | Early ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C17:0 | 11.3 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C17:0 | 11.5 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 11.6 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 11.7 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C17:0 | 12.1 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 12.7 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C17:0 | 13 | nM | Early ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C17:0 | nM | Late ITT Infusion Study | 30 mins |